2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
several genes that code for ion channels have been implicated in the<br />
LQTS which exists in two main forms: (i) Romano Ward syndrome<br />
inherited as autosomal dominant, and (ii) Jervell and Lange-Nielsen<br />
syndrome, an autosomal recessive disorder which is associated with<br />
sensorineural deafness .<br />
Here we present result <strong>of</strong> genetic linkage analysis on a family with a<br />
history <strong>of</strong> sudden death in three children at the age <strong>of</strong> 7 to 8 years .<br />
Screening the other four living children and their consanguineous parents<br />
revealed that two sons were affected with prolonged QT intervals<br />
with unremarkable hearing assessment . Whole genome scan using<br />
Allegro s<strong>of</strong>tware identified a locus on chromosome 5q31-34 with a<br />
maximum positive LOD score <strong>of</strong> 2 .05 . This locus has not been described<br />
in association with the LQTS . Further analysis <strong>of</strong> the region<br />
with sequencing <strong>of</strong> potential candidate genes is in progress .<br />
In this work, we report on the identification <strong>of</strong> a novel locus for the<br />
LQTS . In the absence <strong>of</strong> hearing loss, the autosoml recessive pattern<br />
<strong>of</strong> inheritance in our family suggests a new form <strong>of</strong> the LQTS . Furthermore,<br />
identifying the causative gene on this locus may provide insight<br />
into the genetic susceptibility to unexplained sudden death in general .<br />
P06.161<br />
LRP1, a candidate gene for risk modulation <strong>of</strong> premature<br />
cardiovascular disease in heterozygous familial<br />
hypercholesterolemia<br />
R. Aledo 1 , V. Llorente-Cortés 1 , R. Alonso 2,3 , P. Mata 2,3 , L. Badimon 1,4 ;<br />
1 Cardiovascular Research Institute, <strong>Barcelona</strong>, Spain, 2 Fundación Jiménez<br />
Diaz, Madrid, Spain, 3 Fundación Hipercolesterolemia Familiar, Madrid, Spain,<br />
4 CIBEROBN-Instituto Salud Carlos III, <strong>Barcelona</strong>, Spain.<br />
Heterozygous familial hypercholesterolemia (hFH) is characterized by<br />
severely elevated LDL-cholesterol levels and premature atherosclerosis<br />
and cardiovascular disease (PCVD) . Genetic alterations <strong>of</strong> the<br />
LDL-receptor gene are the main cause <strong>of</strong> this disease . However, there<br />
is a substantial variation in the onset and severity <strong>of</strong> the disease . This<br />
variability might be due to atherogenic risk factors <strong>of</strong> environmental,<br />
metabolic and genetic origin modulating the phenotype <strong>of</strong> hFH disease<br />
. LDL-receptor-related receptor (LRP1) is a multiligand binding<br />
receptor that acts as a pivotal lipoprotein receptor for the atherotrombotic<br />
transformation <strong>of</strong> the vascular wall . The aim <strong>of</strong> this study was<br />
to analyse the association <strong>of</strong> LRP1 polymorphisms with premature<br />
cardiovascular disease in 339 hFH-patients (262 PCVD and 77 non-<br />
PCVD) from the Spanish FH Register . The polymorphisms c .1-25 C>G,<br />
rs715948, rs1799986, rs1800127, rs7968719, rs1800176, rs1800194,<br />
rs1800181, rs1140648, rs1800164 distributed along the whole gene<br />
were used in the study . The polymorphism rs1799986 showed a significant<br />
association with PCVD in the codominant model for the heterozoygous<br />
genotype CT (nominal P = 0 .0126, OR 2 .07 . CI 95 1 .14-3 .74)<br />
.The functional effect <strong>of</strong> rs1799986, that apparently is a synonymous<br />
mutation (Asp100Asp), was analyzed by the web interface http://pupasuite<br />
.bioinfo .cipf .es . This polymorphism completely abolishes an<br />
Exonic Splicing Enhancer sequence . This may results in splicing aberrations<br />
as exon skipping and therefore in a deficient transcription <strong>of</strong> the<br />
gene. Although further studies are needed to confirm the rs1799986<br />
association with atherosclerosis and cardiovascular risk and to clarify<br />
its physiological role, our results suggest that this polymorphism is a<br />
biological plausible risk factor for PCVD .<br />
P06.162<br />
No association between polymorphic loci <strong>of</strong> the G gene and<br />
major depressive disorder.<br />
A. Gareeva, T. Noskova, E. Khusnutdinova;<br />
Institute <strong>of</strong> Biochemistry and <strong>Genetics</strong> <strong>of</strong> Ufa Scientific center <strong>of</strong> Russian academy<br />
<strong>of</strong> Sciences, Ufa, Russian Federation.<br />
Major depressive disorder (MDD) is a common and highly heterogeneous<br />
psychiatric disorder encompassing a spectrum <strong>of</strong> symptoms<br />
involving deficits to a range <strong>of</strong> cognitive, psychomotor and emotional<br />
processes. The flavoprotein D-amino acid oxidase (DAO) degrades the<br />
gliotransmitter D-Ser, a potent activator <strong>of</strong> N-methyl-D-aspartate-type<br />
glutamate receptors . A body <strong>of</strong> evidence suggests that DAO, together<br />
with its activator, G72 protein, may play a key role in the pathophysiology<br />
<strong>of</strong> MDD The present study tested the hypothesis that the M23<br />
and M15 polymorphic loci <strong>of</strong> the G72 gene are associated with major<br />
depressive disorder (MDD) . We studied M23 and M15 polymorphic<br />
loci <strong>of</strong> the G72 gene in 163 MDD patients and in 268 normal controls<br />
from Bashkortostan region (belonged to Russian and Tatars ethnic<br />
groups). No significant differences were demonstrated for genotype or<br />
allele frequency <strong>of</strong> the M23 and <strong>of</strong> M15 polymorphic loci <strong>of</strong> G72 gene<br />
comparing the MDD and control group . The patient and the control<br />
samples were not divided according ethnicity, because genotype and<br />
allele frequencies were coincide in patient and control sample . Haplotype<br />
analysis was conducted to assess the association between the<br />
two markers within the G72 gene . The results showed that these two<br />
markers are in no linkage disequilibrium (LD): D’ (patient sample) =<br />
0.056, D’ (control sample) = 0.064. Our findings suggest that M23 and<br />
M15 polymorphic loci <strong>of</strong> the G72 gene do not play a major role in the<br />
susceptibility to MDD . However, further studies with a larger sample<br />
are required to confirm the obtained results.<br />
P06.163<br />
search for genetic mechanisms involved in malaria infection in<br />
Amazon<br />
R. G. M. Ferreira 1 , L. M. Garrido 1 , C. E. M. Kawamata 1 , L. M. A. Camargo 2 , H.<br />
Krieger 1 ;<br />
1 Departmento de Parasitologia, Instituto de Ciências Biomédicas, Universidade<br />
de São Paulo, Brazil, São Paulo, Brazil, 2 Universidade São Lucas, Porto Velho,<br />
Brazil.<br />
The biochemical pathways involved in the pathogenesis <strong>of</strong> the parasite<br />
infection that causes malaria and the human host mechanisms <strong>of</strong><br />
defense against it are still not entirely know . Epidemiologic studies,<br />
as well genetic studies, suggest the existence <strong>of</strong> genetic components<br />
related to the host innate resistance or susceptibility to malaria (Hill<br />
A .V .,2006) . Based on results obtained by our group in a genome-wide<br />
scan in 182 individuals from Portuchuelo (8 o 37’S, 63 o 49’W), Rondonia<br />
state, Brazil (Ferreira R .G .M . et al.,2007) . The following STRs markers<br />
in the short arm <strong>of</strong> chromosome 4 spanning from 0 to 57cM where selected<br />
to be genotyped in a distinct population, Monte Negro (10 o 15’S,<br />
63 o 18’W), at the same Brazilian state .<br />
The sample, 452 individuals from nuclear families, was genotyped using<br />
7 SRTs markers (D4S412 - 4 .74cM, D4S2983 - 17 .5cM, D4S403<br />
- 25cM, D4S419 - 30cM, D4S3022 - 36cM, D4S391 - 43 .6cM, D4S405<br />
- 57cM) along short arm <strong>of</strong> chromosome 4, with a mean distance <strong>of</strong><br />
8 .74cM from each other . The s<strong>of</strong>tware SimWalk2 (Sobel E . et al .,2002)<br />
was used to check mendelian segregation <strong>of</strong> the alleles in the families<br />
.<br />
The reported number <strong>of</strong> malarial episodes, corrected by age and sex,<br />
was used as the quantitative trait phenotype . This phenotype showed<br />
expected association with Fy- individuals as well as familial aggregation<br />
in conformity with genetic mechanisms, indicating its epidemiological<br />
importance . Linkage analysis were conducted using the s<strong>of</strong>tware<br />
Solar 2 (Almasy L . et al .;1998) .<br />
No evidence <strong>of</strong> linkage was found both in multi-point and two-point<br />
analysis . (FAPESP,CNPq)<br />
P06.164<br />
matrix metalloproteinase-3 gene polymorphism and dilatative<br />
pathology <strong>of</strong> ascending thoracic aorta<br />
G. Sinkunaite, V. Lesauskaite, R. Benetis, A. Smalinskiene, S. Simonytë, G.<br />
Jariene, V. Tatarunas, J. Petkeviciene, J. Klumbiene;<br />
Institute <strong>of</strong> Cardiology, Kaunas University <strong>of</strong> Medicine, Kaunas, Lithuania.<br />
The aim <strong>of</strong> the study was to identify whether the mutation in the promoter<br />
region <strong>of</strong> MMP3 gene might be a determinant <strong>of</strong> dilatative pathology<br />
<strong>of</strong> ascending thoracic aorta (DP ATA) .<br />
Material and methods . We studied 76 (55 males, 21 females) patients<br />
with DP ATA, the age ranged from 31 to 81 years (median, 64 years)<br />
and a random sample <strong>of</strong> the population ((244 males and 366 females)<br />
aged 25-64 yrs ., all from Lithuania . Analysis was done on DNA using<br />
real-time polymerase chain reaction to genotype polymorphism 5A/6A<br />
at a position -1171 <strong>of</strong> the MMP3 gene promoter .<br />
Results . The prevalence <strong>of</strong> MMP-3 genotypes was similar between<br />
group <strong>of</strong> DP ATA and random sample <strong>of</strong> population . The frequency <strong>of</strong><br />
5A allele did not differ between both groups and was 0 .506 and 0 .514,<br />
respectively. Male patients carrying 5A/5A genotype were significantly<br />
younger compared with those with the 6A/6A genotype .<br />
In conclusion, the frequency <strong>of</strong> MMP-3 promoter 5A/6A genotypes did<br />
not differ between the group <strong>of</strong> patients with DP ATA and the random<br />
sample <strong>of</strong> population, but the males with DP ATA and 5A/5A genotype<br />
required aortic reconstruction surgery at the younger age than the